| Serial Number | 87742107 |
| Word Mark | ALLERGAN |
| Filing Date | Wednesday, January 3, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 13, 2021 |
| Registration Number | 6420206 |
| Registration Date | Tuesday, July 13, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 17, 2018 |
| Goods and Services | House mark used for a line of pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations, and pharmaceutical preparations to treat and prevent glaucoma; ocular wetting solutions, namely, eye drops, artificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, central nervous system disorders, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; medicated cosmetic skin care preparations |
| Goods and Services | House mark used for a line of surgical, medical, dental and veterinary apparatus and instruments, namely, diagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; medical devices for treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for use in facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics and ophthalmic related diseases and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 18, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, June 30, 2017 |
| First Use In Commerce Date | Friday, June 30, 2017 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 18, 2018 |
| Primary Code | 010 |
| First Use Anywhere Date | Friday, June 30, 2017 |
| First Use In Commerce Date | Friday, June 30, 2017 |
| Party Name | Allergan Sales, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Madison, NJ 07940 US |
| Party Name | Allergan Sales, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Madison, NJ 07940 US |
| Party Name | Allergan Sales, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Madison, NJ 07940 US |
| Event Date | Event Description |
| Saturday, January 6, 2018 | NEW APPLICATION ENTERED |
| Thursday, January 18, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 13, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, March 14, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 28, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 17, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 17, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 12, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, November 29, 2018 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 29, 2018 | SOU EXTENSION 1 FILED |
| Thursday, November 29, 2018 | SOU EXTENSION 1 GRANTED |
| Saturday, December 1, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 29, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, June 12, 2019 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, June 12, 2019 | SOU EXTENSION 2 FILED |
| Wednesday, June 12, 2019 | SOU EXTENSION 2 GRANTED |
| Friday, June 14, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 6, 2019 | SOU TEAS EXTENSION RECEIVED |
| Friday, December 6, 2019 | SOU EXTENSION 3 FILED |
| Friday, December 6, 2019 | SOU EXTENSION 3 GRANTED |
| Tuesday, December 10, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 12, 2020 | SOU TEAS EXTENSION RECEIVED |
| Friday, June 12, 2020 | SOU EXTENSION 4 FILED |
| Friday, June 12, 2020 | SOU EXTENSION 4 GRANTED |
| Tuesday, June 16, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 10, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 29, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, December 10, 2020 | SOU EXTENSION 5 FILED |
| Tuesday, December 29, 2020 | SOU EXTENSION 5 GRANTED |
| Wednesday, December 30, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 4, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Friday, June 4, 2021 | USE AMENDMENT FILED |
| Monday, June 7, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, June 8, 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, June 9, 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, July 13, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Monday, July 6, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, July 6, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, July 6, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, July 6, 2026 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |